SHOW ME

PRESS
Apr 18, 2025

Transplant Therapeutics Consortium Receives FDA Acceptance of the Qual...

MOUNT LAUREL, N.J., Nov. 20, 2024 /PRNewswire/ — The American Society of Transplant Surgeons (ASTS) and American Society of …
PRESS
May 17, 2024

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and U...

NEW YORK, May 17, 2024 — J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United …
PRESS
Apr 4, 2024

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and U...

NEW YORK, April 4, 2024 /PRNewswire/ — J.P. Morgan Asset Management’s Life Sciences Private Capital, Blue Horizon Advisors and …
PRESS
Mar 5, 2024

Patient Care America Announces Acquisition of Lyfebulb

Combining Resources to Create the Premier, Patient-Focused Renal Solutions Provider  POMPANO BEACH, Fla. and NEW YORK, March 5, 2024 /PRNewswire/ — Patient …
PRESS
Nov 16, 2023

J.P. Morgan Life Sciences Private Capital Partners with Blue Horizon A...

Application Period Opens Today, November 16, 2023 NEW YORK, Nov. 16, 2023 /PRNewswire/ — J.P. Morgan Asset Management’s Life Sciences …
PRESS
Jul 14, 2023

Karin Hehenberger: Paying The Gift Of Life Forward
PRESS
Apr 4, 2023

Lyfebulb’s Karin Hehenberger, MD, PhD, Makes Inc.’s 2023 Female Founde...
PRESS
Jan 26, 2023

OstoBuddy and South Asian IBD Alliance Named Winners of Innovation Cha...
PRESS
Jan 10, 2023

Lyfebulb Launches RareCancerLyfe, A Digital Platform to Support the Ra...
PRESS
Nov 28, 2022

Westport Doctor named Runner-Up for Chris Klug Foundation Award
PRESS
Sep 20, 2022

Lyfebulb Seeks Applicants for the Global 2022 Innovation Challenge, in...

NEW YORK September 20, 2022 — Lyfebulb, a patient-empowerment platform that connects patientswith industry experts to support …
PRESS
Sep 19, 2022

­Lyfebulb and Veloxis Pharmaceuticals Announce Finalists for 2022 Inno...

NEW YORK and NORTH CAROLINA, September 19, 2022 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that connects patients with …